WEN-RAY HSU: Open Payments
NPI 1326135468 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$753 in 24 payments from 5 companies in 2025. Trend: 2023 $1,168 · 2024 $493 · 2025 $753
Food & beverage: $753
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $317 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $146 |
| GlaxoSmithKline, LLC. | 5 | $140 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $125 |
| Lilly USA, LLC | 1 | $24 |
Products named: AIRSUPRA, JARDIANCE, BREZTRI, TRELEGY ELLIPTA, Kerendia, MOUNJARO.
Industry payments across NY — which companies pay providers there.
